More than two million doses of vaccines are set to arrive in Canada this week as the country scrambles to contain the wildfire spread of more contagious variants of the COVID-19 virus. That includes the first batch of Oxford-AstraZeneca vaccines — 316,800 doses — to be sent to Canada from the global vaccine-sharing initiative known as the COVAX Facility. Canada has contributed $440 million to COVAX, half to secure up to 15 million doses of vaccines for Canada and half to buy vaccines for poorer countries that can’t afford to purchase their own. While any member country can draw on COVAX’s supplies for its own use, Canada has been heavily criticized for undermining the spirit of the COVAX initiative, which is to ensure vaccines are equitably distributed to poor countries. In addition to the COVAX supply, Canada is to receive 1,019,070 doses of the Pfizer-BioNTech vaccine and 855,600 doses of the Moderna vaccine over the next seven days. That’s almost 2.2 million doses in total, following a peak of more than three million doses last week.